ABBV vs. ABT
Compare and contrast key facts about AbbVie Inc. (ABBV) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or ABT.
Key characteristics
| ABBV | ABT | |
|---|---|---|
| YTD Return | 5.74% | -2.83% |
| 1Y Return | 12.12% | -3.30% |
| 3Y Return (Ann) | 16.51% | -2.21% |
| 5Y Return (Ann) | 20.75% | 7.95% |
| 10Y Return (Ann) | 16.83% | 12.71% |
| Sharpe Ratio | 0.56 | -0.17 |
| Daily Std Dev | 18.37% | 17.88% |
| Max Drawdown | -45.09% | -45.62% |
| Current Drawdown | -10.87% | -21.58% |
Fundamentals
| ABBV | ABT | |
|---|---|---|
| Market Cap | $282.63B | $186.58B |
| EPS | $2.71 | $3.22 |
| PE Ratio | 58.90 | 33.39 |
| PEG Ratio | 0.45 | 5.99 |
| Revenue (TTM) | $54.40B | $40.33B |
| Gross Profit (TTM) | $41.53B | $24.58B |
| EBITDA (TTM) | $26.88B | $10.34B |
Correlation
The correlation between ABBV and ABT is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABBV vs. ABT - Performance Comparison
In the year-to-date period, ABBV achieves a 5.74% return, which is significantly higher than ABT's -2.83% return. Over the past 10 years, ABBV has outperformed ABT with an annualized return of 16.83%, while ABT has yielded a comparatively lower 12.71% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABBV vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABBV vs. ABT - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.77%, more than ABT's 2.00% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.77% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% | 3.03% |
ABT Abbott Laboratories | 2.00% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% | 1.46% |
Drawdowns
ABBV vs. ABT - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, roughly equal to the maximum ABT drawdown of -45.62%. Use the drawdown chart below to compare losses from any high point for ABBV and ABT. For additional features, visit the drawdowns tool.
Volatility
ABBV vs. ABT - Volatility Comparison
AbbVie Inc. (ABBV) has a higher volatility of 8.21% compared to Abbott Laboratories (ABT) at 5.11%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABBV vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities